Finland· FI-REL-REL2524

Orthoclone Okt 3

A muromonab-cd3 product containing muromonab-cd3, registered in Finland by Janssen-Cilag Oy. The same ATC class is registered in 2 of our 19 countries.

ATC L04AG01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedOrthoclone Okt 3ATCL04AG01REGISTER NO.FI-REL-REL2524PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Muromonab-cd3 is registered in 2 of 19 countries.

Countries holding a registration under ATC L04AG01 (muromonab-cd3), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Muromonab-cd3 · ATC L04AG01

2 / 19 countries

  • Finlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Muromonab-cd3
Manufacturer
Janssen-Cilag Oy
Country
Finland (FI)
ATC code
L04AG01
ATC class
Muromonab-CD3
Defined daily dose
5 mg, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Muromonab-cd3 in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All muromonab-cd3 products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f907569a-4692-44e3-964b-04a8c5d8f279
GET /v1/drugs/f907569a-4692-44e3-964b-04a8c5d8f279?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "5",
  "form": "injektioneste, liuos",
  "route": null,
  "ddd_unit": "mg",
  "strength": "1 mg/ml",
  "atc_label": "muromonabi-CD3",
  "ma_number": "9992",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL2524",
  "authorised_at": "1989-06-14"
}

See everything about muromonab-cd3.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.